Around the world, more than 200 million people suffer from diabetes, and approximately 18.2 million Americans are affected by this disease. Diabetes is characterized by a high sugar (glucose) level in the blood, which comes as a result of insufficient insulin production in the body, impaired cellular response to it, or both. read more...

Cellular Medicine™ provides a breakthrough in understanding the cause, prevention, and adjunct management of diabetes.

The primary reason why adult onset diabetes (Type II) develops is a long-term deficiency of specific cellular micronutrients that work in synergy in millions of cells in the pancreas (the organ that produces insulin), the liver, and the blood vessels walls. This new understanding also explains the reason for most severe consequences of diabetes, which are circulatory problems. Diabetes significantly increases the chance of developing atherosclerotic deposits, which by clogging the blood vessels can increase the risk of heart attacks, feet amputation or blindness etc.

This concept was tested in a pilot clinical trial in patients with Type II diabetes. ...read less

Aim of the StudyAim of the Study

To test the effectiveness of the specific combination of cellular nutrients on blood sugar levels in patients suffering from Type II diabetes. ...hide content

Study DesignStudy Design

Pilot clinical study was conducted in 10 patients suffering from Type II Diabetes also called adult onset diabetes. These patients took a specific micronutrient program comprising vitamins, amino acids and minerals, such as chromium, for 6-months. Blood tests were conducted to measure the effect of this nutrient synergy on blood glucose levels as well as HbA1-c levels (indicator of damage to red blood cells by glucose). before using this micronutrient program, after two months, after four months and after six months of its use. ...hide content

Study ResultsStudy Results

After 6 months of following the Cellular micronutrients program there was a decrease in blood sugar level by 23 % (from an average of 155mg/dl at the beginning of the study to 120 mg/dl at the end of the study). In addition, the HbA1-c levels in the blood were lower by an average of 9.3%. ...hide content

ConclusionConclusion

This six-month pilot study, though conducted with a small group of patients, confirmed the positive effects of the synergistic combination of cellular nutrients on regulating blood sugar levels in diabetic patients without any side effects. The effectiveness of the synergistic action of nutrients in type II diabetes has been further confirmed by several testimonials based on patient medical records. ...hide content

Hundreds of millions of people have elevated blood levels of cholesterol, triglycerides, LDL (low density lipoproteins), lp(a) and other lipoproteins. According to Cellular Health™, these are actually secondary risk factors for cardiovascular disease and the consequence of ongoing vascular disease, with the primary cause being instability of blood vessel walls. Conventional medicine considers genetic and dietary risks to be the main causes of elevated cholesterol blood levels. If a change of diet doesn’t help, the medical community commonly reaches for harmful cholesterol-lowering drugs and other medicines to suppress symptoms, without addressing the underlying cause of fat metabolism problems, which is blood vessel weakness.

Aim of the StudyAim of the Study

Cellular Health™ opens up the possibility of the effective prevention and control of lipid metabolism disorders through the targeted use of nutrients synergy, such as specific vitamins, minerals, and amino acids. These micronutrients help strengthen the artery walls, thus reducing the need for elevated production in the liver of triglycerides, cholesterol, lipoprotein(a), and other risk factors that are used as “repair” factors for weak arterial walls. Thus, the primary measure for lowering cholesterol and other secondary risk factors in the bloodstream is to stabilize the artery walls, thereby decreasing the metabolic demand for the excess production of these risk factors in the liver. The nutrient synergy program tested in the study had a unique dual action. This program not only controlled the blood cholesterol and other lipid levels, but it also nourished and improved the condition of the blood vessel walls.

Following are the interim results of two clinical pilot studies in patients with elevated cholesterol and lipoprotein(a) plasma levels who have been following a nutrient synergy program for three months. ...hide content

Study DesignStudy Design

Fourteen patients, between the ages of 34-68 and suffering from fat metabolism disorders, were the participants in this study. They took daily dosages of specific cellular nutrients for three months. At the same time, they continued to take their usual prescription medications. To obtain interim results, blood tests were obtained at the beginning of the study and following twelve weeks of vitamin treatment. ...hide content

Interim Study ResultsInterim Study Results

At the beginning of the study, the average blood lipoprotein(a) level of patients was 71 mg/dl (Figure 1), and the average total cholesterol level was 293 mg/dl (Figure 2). After three months on the vitamin program, the average level of lp(a) decreased by 13%. Total cholesterol in all patients decreased by 14%, LDL decreased by 10%, triglycerides decreased by 22% and homocysteine decreased by 3%. HDL (good cholesterol) increased in this time period by 8%. It is important to note the decrease of lp(a) levels since there is no successful conventional treatment available to lower this significant blood risk factor for heart disease. Lipoprotein(a) is a tenfold greater risk factor for heart disease than cholesterol or LDL cholesterol.

Currently, we are evaluating the six-month pilot study results in patients with elevated blood cholesterol and other lipid levels. However, patients have immediately taken advantage of Dr. Rath’s discovery and his nutrient synergy program, and we received numerous testimonials that are supported by medical data. ...hide content

The coronary arteries provide the primary blood supply to the heart muscle, and coronary heart disease occurs when the arteries become blocked by a buildup of, calcium, cholesterol, and other blood factors. This fatty buildup is medically referred to as atherosclerosis, and these deposits cause the arteries to narrow and stiffen. A sudden block of the blood supply to any area of the heart muscle can cause heart attack and death.

Aim of the StudyAim of the Study

The objective of this study was to determine the effect of a defined nutritional supplement program and specific nutrient synergy on the natural progression of coronary artery disease in 55 patients (50 men and 5 women) between the ages of 44-67 with coronary artery disease as documented by Ultrafast Computed Tomography. ...hide content

Study DesignStudy Design

The study focused directly on the key problem - the atherosclerotic deposit inside the walls of the coronary arteries. For this study, Ultrafast Computed Tomography (UCT) was used. UCT is a modern technique that allows the measurement of the size of coronary deposits non-invasively. The computer automatically calculates a deposit’s size by determining the Coronary Artery Scan (CAS) score. The higher the CAS score, the more calcium has accumulated, which indicates more advanced coronary heart disease. Changes in the size of the coronary artery calcifications in each patient were measured over an average period of one year without vitamin supplementation followed by one year with the vitamin program. In this way, the heart scans of the same person was compared before and after the vitamin program. This study design had the advantage of the patients serving as their own controls. ...hide content

Study ResultsStudy Results

During the course of the 12-month nutritional supplement program, the fast growth of coronary deposits was slowed during the first six months of the study and essentially stopped during the second six months. After one year of using the specific supplement program, the coronary deposits entirely disappeared, indicating on a natural healing process of the artery wall.

For the first time in medical history, the reversal of atherosclerotic deposits without bypass surgery, angioplasty, and medication was documented. The results of this remarkable discovery were published in the Journal of Applied Nutrition in 1996.

...hide content

Asthma is a disorder characterized by narrowing of the lung passageways, making breathing difficult. Symptoms include recurrent attacks of shortness of breath, coughing, and wheezing. Hundreds of millions of people worldwide suffer from this illness. We are aware of many of the factors that cause asthma, but conventional medicine offers therapy only for the symptoms.

Aim of the StudyAim of the Study

Cellular Health™ opens up the possibility of effective prevention and treatment of asthma through the targeted use of micronutrients such as vitamins, minerals, and amino acids. This ongoing study tests the effects of specific vitamins on lung function in patients diagnosed with asthma. Below are the results of cellular nutrients after three months of treatment. ...hide content

Study DesignStudy Design

Eight asthma patients, between the ages of 45-75 years, are participating in the ongoing study. The subjects are taking a daily dosage of a specific nutrient combination for the six-month study period. They also continue to take their usual prescription medicines.

All asthma patients underwent pulmonary function tests at the beginning of the study and after three months (mid-point). Subsequent tests will be performed after six months of taking the specific nutrient combinations. Lung volume was measured by testing the maximal volume of exhalation after a maximal inhalation. ...hide content

Study ResultsStudy Results

After only three months on vitamin therapy, all (100%) the patients demonstrated increased lung capacity (see diagram). This means that during this relatively short period, all patients experienced an improvement in their breathing.

As soon as this pilot study is completed and we have results from the full six months of treatment, we will provide complete documentation.  ...hide content